Clinical Trial Update: Thalidomide in the Treatment of Chronic Radiation Proctitis With Intractable Bleeding [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating thalidomide for chronic radiation proctitis with intractable bleeding; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Proctitis

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Chronic Radiation Proctitis | Phase 2 | Status: UNKNOWN